Effective April 10, 2023, masking is optional in all NYOH sites for patients and employees.
Make First Appointment Refer a Patient

Clinical Trials & Research

Home / Clinical Trials & Research / View Open Trials / 19151 - Ph1/2 MRTX849 Solids KRAS G12C

19151 - Ph1/2 MRTX849 Solids KRAS G12C

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

Disease Types: Solid Tumors,&nbs

Available at: {clinical_trial_location backspace="7"}19151 - Ph1/2 MRTX849 Solids KRAS G12C, {/clinical_trial_location}

Principal Investigator: {clinical_trial_principle_investi} , {/clinical_trial_principle_investi}

{clinical_trial_description}